DO34 analog
DO34 analog is a triazole DAGL (α) inhibitor extracted from patent WO2017096315 A1, compound 100.
Product Specifications
CAS Number
2098969-71-0
Product Name Alternative
PK-8165
UNSPSC
12352005
Target
DAGL
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/DO34_analog.html
Purity
98.42
Solubility
DMSO : ≥ 105 mg/mL
Smiles
O=C(N1C(CC2=CC=CC=C2)CN(C(OC(C)(C)C)=O)CC1)N3N=CC(C4=CC=C(OC(F)(F)F)C=C4)=N3
Molecular Formula
C26H28F3N5O4
Molecular Weight
531.53
References & Citations
[1]WO 2017096315 A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC042676-500 1x 500 µL
PD-L2 / PDCD1LG2 / CD273 (PDL2/2676), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
TRC-D459100-25MG 25 mg
(2R,3R,4S,5R)-1,2:4,5-Di-O-isopropylidene-3-nonadecanol
Sign In for Pricing
View Details 